Gemcitabine/ifosfamide/pirarubicinLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1950卷 / 1期

关键词：

D O I：

10.1007/s40278-023-36600-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：203 / 203

相关论文

共 50 条

[1] Cisplatin/gemcitabine/pirarubicinLack of efficacy: case report
Reactions Weekly, 2023, 1952 (1) : 125 - 125
[2] Epirubicin/pirarubicinLack of efficacy: case report
Reactions Weekly, 2024, 2023 (1) : 161 - 161
[3] Antineoplastics/pirarubicinLack of efficacy : case report
Reactions Weekly, 2022, 1921 (1) : 46 - 46
[4] Antineoplastics/pirarubicinLack of efficacy: case report
Reactions Weekly, 2022, 1900 (1) : 60 - 60
[5] Ifosfamide/vincristineLack of efficacy: case report
Reactions Weekly, 2022, 1887 (1) : 371 - 371
[6] Ifosfamide/methotrexateLack of efficacy: case report
Reactions Weekly, 2021, 1852 (1) : 221 - 221
[7] Doxorubicin/ifosfamide/mesnaLack of efficacy : case report
Reactions Weekly, 2023, 1949 (1) : 187 - 187
[8] Cisplatin/ifosfamide/paclitaxelLack of efficacy: case report
Reactions Weekly, 2023, 1958 (1) : 151 - 151
[9] Doxorubicin/ifosfamide/mesnaLack of efficacy: case report
Reactions Weekly, 2023, 1958 (1) : 198 - 198
[10] Ifosfamide/levetiracetamEncephalopathy and lack of efficacy: case report
Reactions Weekly, 2022, 1896 (1) : 238 - 238

← 1 2 3 4 5 →